Intranasal immunization with live-attenuated RSV-vectored SARS-CoV-2 vaccines elicits antigen-specific systemic and mucosal immunity and protects against viral challenge and natural infection
Davide Botta, Michael D. Schultz, Aarón Silva-Sánchez, Davies Kalange, Jobaida Akther, Fen Zhou, Jennifer L. Tipper, Guang Yang, Levi Schaefers, Courtney A. Barkley, Shihong Qiu, Jeremy B. Foote, Mariana F. Tioni, Christopher M. Weiss, Shannon I. Phan, , Frances E. Lund
This study evaluates two RSV-vectored SARS-CoV-2 vaccines, showing they induce systemic and mucosal immunity and protect against viral challenge and natural infection.
Vaccines · Apr 29, 2026Peer-reviewedImmunology